Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 [azelastine] and MP03-33 Compared to Placebo in Patients With Seasonal Allergic Rhinitis.

Trial Profile

Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 [azelastine] and MP03-33 Compared to Placebo in Patients With Seasonal Allergic Rhinitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Nov 2010

At a glance

  • Drugs Azelastine (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors Meda Pharmaceuticals
  • Most Recent Events

    • 05 Nov 2009 Results were presented at ACAAI 2009.
    • 01 Nov 2009 Results published in Allergy and Asthma Proceedings.
    • 22 May 2009 Actual patient number (526) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top